Incidence and Risk Factors for Rejection After Conversion to Sirolimus-Based Immunosuppression in Orthotopic Heart Transplant Recipients

被引：0
|
作者：
Inglis, S. [1 ]
Abbas, M. [1 ]
Asleh, R. [1 ]
Kushwaha, S. [1 ]
Clavell, A. [1 ]
Villavicencio, M. [1 ]
Spencer, P. [1 ]
Daly, R. [1 ]
Behfar, A. [1 ]
Rosenbaum, A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
197
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients
    Yu, Si
    He, Xiaoshun
    Yang, Lu
    Ma, Yi
    Zhu, Xiaofeng
    Ju, Weiqiang
    Huang, Jiefu
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2008, 6 (02) : 113 - 117
  • [2] Proteinuria after Conversion to Sirolimus-Based Immunosuppression in Cardiac Transplant Recipients: A Five Year Analysis
    Raichlin, E.
    Al-Omari, M. A.
    Edwards, B. S.
    Daly, R. C.
    Frntz, R. F. P.
    Clavell, A. C. L.
    Pereira, N. L.
    Schirger, J. A.
    Kushwaha, S. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S50 - S51
  • [3] Platelet activation markers after conversion from azathioprine to sirolimus-based immunosuppression in renal transplant recipients
    Graff, Jochen
    Harder, Sebastian
    Reiche, Claudia
    Scheuermann, Ernst-Heinrich
    Gossmann, Jan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (12) : 873 - 879
  • [4] Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression
    El-Agroudy, Amgad E.
    El-Dahshan, Khaled F.
    Wafa, Ehab W.
    Sheashaa, Hussien A.
    Gad, Ziad A.
    Ismail, Amani M.
    Shokeir, Ahmed A.
    Ghoneim, Mohamed A.
    NEPHROLOGY, 2009, 14 (02) : 255 - 261
  • [5] Calcineurin-Inhibitor Free Sirolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients
    Rossano, Joseph W.
    Ryan, Rachel M.
    Orfanelli, Laura
    McCandless, Karen V.
    Kaufman, Beth D.
    Lin, Kimberly Y.
    Paridon, Stephen M.
    Hanna, Brian D.
    Shaddy, Robert E.
    CIRCULATION, 2012, 126 (21)
  • [6] Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients
    Sundberg, AK
    Rohr, MS
    Hartmann, EL
    Adams, PL
    Stratta, RJ
    CLINICAL TRANSPLANTATION, 2004, 18 : 61 - 66
  • [7] Sirolimus-Based Immunosuppression for Treatment of Cutaneous Warts in Kidney Transplant Recipients
    Shahidi, Shahrzad
    Moeinzadeh, Firouzeh
    Mohammadi, Morteza
    Gholamrezaei, Ali
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2011, 5 (05) : 351 - 353
  • [8] Impact of Conversion to Sirolimus-Based Immunosuppression on Fibrosis Progression in HCV plus Liver Transplant Recipients.
    Stevens, D. R.
    Curry, M. P.
    Nandy, N.
    Nasser, I.
    Challies, T.
    Rogers, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 46 - 46
  • [9] Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients
    Toso, C
    Morel, P
    Bucher, P
    Mathe, Z
    Demuylder-Mischler, S
    Bosco, D
    Berney, T
    Oberholzer, J
    Shapiro, J
    Oberholzer, J
    Philippe, J
    TRANSPLANTATION, 2003, 76 (07) : 1133 - 1134
  • [10] Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients
    Tohme, F. A.
    Kalil, R. S.
    Thomas, C. P.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (01) : 66 - 72
12345